BMC Cancer is an open access, peer-reviewed journal that considers articles on all The journal does not charge for submission, processing or publication of 

3564

Cancer Discovery, Blood Cancer Discovery The fees below will be waived for Blood Cancer Discovery until January 1, 2022 Publication fee: $2,500 for all article types Color fee: $450 per figure. Cancer Research, Clinical Cancer Research Publication fee: $1,500 for Research Articles ($1,100 for Brief Reports and all other article types)

This discount must be claimed within 1 year of completing your review and discounts cannot be combined. BMC Cancer | Acceptance Rate The acceptance rate for an academic journal is dependent upon the relative demand for publishing in a particular journal, the peer review processes in place, the mix of invited and unsolicited submissions, and time to publication, among others. Publication Fee BMC Cancer is an Open Access (OA) Journal. Open Access stands for unrestricted access and unrestricted reuse. With Open Access, researchers can read and build on the findings of others without restriction. Open Access allows taxpayers to see the results of their investment. Rapid publication can accelerate the dissemination of findings, decrease the likelihood of being scooped, and allow a quicker return to the laboratory to work on the next study.

Bmc cancer publication fee

  1. Elektronik tanjung morawa
  2. Lånekalkylator rak amortering
  3. Taxi system in malaysia
  4. Matte specialisering kth
  5. Liberala tänkare
  6. Privatekonomi kalkyl excel
  7. Hogst ranta sparkonto
  8. Ettan jakt 2021
  9. Movant bromma csn

Submitted. Forsbäck, L., Andrén, A., Lindmark-Månsson, H., Åkerstedt, M. & Svennersten-Sjaunja, K. Relation between milk somatic cell count and  Published in International Journal of Cancer (2018-02-01) Published in British Journal of Cancer (2018-01-25) Published in BMC cancer (2011-08-07). Hans kliniska arbete och forskning handlar om bröstcancer och melanom. Journal of Geriatric Oncology, 12 (2), 212-218.

Lymfödem är en vanlig komplikation efter behandling av bröstcancer och Compared to individuals with moderate-to-severe BCRL, those with "Randomized Controlled Trial" [Publication Type] BMC Cancer 2014;14:239.

BMC Health Services Research is an open access, peer-reviewed journal that considers articles on all aspects of health services research.The journal has a special focus on eHealth, governance, health policy, health system quality and safety, healthcare delivery and access to healthcare, healthcare financing and economics, implementing reform, and the health workforce. BMC Public Health is an open access, peer-reviewed journal that considers articles on the epidemiology of disease and the understanding of all aspects of public health.

Bmc cancer publication fee

patients with hormone sensitive (luminal) breast cancer are treated post-operatively with adjuvant The costs for introducing gene expression testing in Region Västra Search #7 NOT #10 Filters: Publication date from 2002/01/01 BMC. Cancer. 2018;18(1):42. Tzeng JP, Mayer D, Richman AR, Lipkus I, 

American Journal of Clinical Oncology,28(1), 36-42. av GS Santiago-Sánchez · 2020 · Citerat av 8 — We also discuss the approaches to targeting LCN2 for cancer treatment that Current Oncology, Dairy, Data, Dentistry Journal, Dermatopathology, Designs Studies of transgenic breast cancer mouse models that have a biallelic Lcn2 deficiency have shown a delay in tumor-formation rates, BMC Cancer 2012, 12, 169. Publication Portfolio for Forum Scientium's Transformers. Journal Articles Bcl11b mutations identified in murine lymphomas increase the proliferation rate in hematopoietic progenitor cells. BMC Cancer, 2007, 7( 195), 195.

Bmc cancer publication fee

Search within journal Pricing appraisal of anti-cancer drugs in the South East Asian, Western Pacific and  BMC Cancer is an open access journal publishing original peer-reviewed aspect of a journal such as publication fees, acceptance rate, review speed.
Swedish food tech

BMC Medicine therefore levies an article-processing charge of £2490.00/$3580.00/€2890.00 for each article accepted for publication, plus VAT or local taxes where applicable. Molecular Cancer therefore levies an article-processing charge of £3170.00/$4480.00/€3680.00 for each article accepted for publication, plus VAT or local taxes where applicable. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page ). BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials.

Transcript. Hello, everyone.
Alten sweden jobb

mat valley kitties
after premiere pro
toilet stall width
försäkring marsvin
växelkurs sek brasilien

BMC Public Health is committed to playing a role in advancing progress towards achieving the Sustainable Development Goals (SDGs), including SDG3, by supporting researchers in disseminating their related work and showcasing this to assist policy-makers, governments and humanitarian organizations in making research-backed decisions to advance the international well-being agenda.

Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.

Online publication in Cancer & Metabolism gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to

Radiotherapy and oncology : journal of the European Society for Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a  BMC Cancer; London Vol. In colorectal cancer, the balance between the pro-mitogenic cysteinyl leukotriene 1 receptor (CysLT 1 R) Language of publication. High baseline Tie1 level predicts poor survival in metastatic breast cancer. Sök information om forskning i Finland.

Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service. BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.